Phase II study of efficacy of bevacizumab and erlotinib in inoperable previously untreated hapatocellular carcinoma (HCC)
Govindarajan R, Siegel E, Makhoul I, Williamson S. Phase II study of efficacy of bevacizumab and erlotinib in inoperable previously untreated hapatocellular carcinoma (HCC). Annual Gastrointestinal Cancers Symposium. 2009.